GlobalData on MSN18d
ITM targets US approval for radiopharmaceutical after Phase III readoutNovartis currently markets Lutathera (lutetium Lu 177 dotatate), an approved peptide ... “With this successful readout, 177Lu ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback